Renaissance Technologies - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 2 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,964
+590.6%
193,474
+570.1%
0.01%
+600.0%
Q2 2023$574
-70.4%
28,874
-74.5%
0.00%
-66.7%
Q1 2023$1,942
-37.5%
113,374
-28.6%
0.00%
-25.0%
Q4 2022$3,108
-100.0%
158,800
-66.9%
0.00%
-63.6%
Q3 2022$7,658,000
+28.3%
479,800
+10.6%
0.01%
+57.1%
Q2 2022$5,970,000
+140.5%
433,900
+177.3%
0.01%
+133.3%
Q1 2022$2,482,000
-25.1%
156,500
+3.1%
0.00%
-25.0%
Q4 2021$3,314,000
-4.0%
151,799
+31.4%
0.00%0.0%
Q3 2021$3,452,000
+287.9%
115,493
+474.6%
0.00%
+300.0%
Q2 2021$890,000
-63.9%
20,100
-63.8%
0.00%
-66.7%
Q1 2021$2,467,000
+88.9%
55,590
-40.6%
0.00%
+200.0%
Q1 2020$1,306,000
+301.8%
93,600
+235.5%
0.00%
Q3 2019$325,000
+7.3%
27,900
+61.3%
0.00%
Q1 2019$303,000
-42.9%
17,301
-51.7%
0.00%
-100.0%
Q4 2018$531,000
-67.7%
35,818
-46.4%
0.00%
-50.0%
Q3 2018$1,645,000
-80.2%
66,825
-84.5%
0.00%
-60.0%
Q2 2018$8,319,000
+164.6%
431,320
+157.2%
0.01%
+66.7%
Q1 2018$3,144,000167,6750.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders